Morning Briefing
November 26, 2024 | Daily JAM, Morning Briefing |
Yesterday in social media posts President-elect Donald Trump said that he would impose tariffs on his first day back in office, targeting the United States’ three largest trading partners, of 25% on all goods from Canada and Mexico until drugs and migrants stopped coming over the borders, and an additional 10% tariff on all products from China, saying that the country was shipping illegal drugs to the United States. (The Biden Administration had already imposed its own higher tariffs on China and, in additional, it had kept tariffs on China from the first Trump Administration in effect.)
November 26, 2024 | Daily JAM, LLY, Morning Briefing, NVO |
The Biden administration has proposed making GLP-1 weight loss drugs free for low-income people and retirees who qualify as obese. Expensive drugs such as Ozempic, Wegovy and Zepbound, which cost $1,000 a month, would be covered for the 40% of the U.S. population who qualify as obese. Currently, the federal plans only cover the drugs when patients have other conditions caused by obesity, such as diabetes, heart disease. The leading drugs are made by Eli Lilly (LLY) and Novo Nordisk (NVO). Shares of Eli Lilly were up 4.55% today while Novo Nordisk rose 1.50%. The incoming Trump Administration will have to decide whether to move ahead with the plan. You can either think of this as a smart piece of health care policy or an effort to jam up an incoming administration that already faces challenges in devising coherent policy on healthcare. I go with the “jam ‘em up” theory myself.
November 25, 2024 | Daily JAM, Dividend Income, Morning Briefing |
Today I added Copa Holdings (CPA), an airline stock paying 6.9% to my Special Report. Here’s what I wrote
November 23, 2024 | Daily JAM, Morning Briefing, Short Term |
I expect more temporizing this week on when to sell a market that everyone agrees is too expensive. It’s especially worthwhile checking on potential tax loss sells as we come out of a great 2024 and head into a much less predictable 2025.
November 22, 2024 | Daily JAM, Morning Briefing |
Let’s start with the 4.54% yield. And then note that, if you hold a bill to maturity, it is essentially risk free. Compare that combination to gold which has a comparable degree of risk but pays a yield of 0%. Or to a 3-month CD where the average U.S. yield is 1.52% or to a 6-month CD where the average U.S. yield is 1.68%.
November 21, 2024 | Daily JAM, Morning Briefing |
Three days after the U.S. election, Redfin, the technology-driven real estate brokerage that does business in 100 markets, raised its projection for the average mortgage rate in 2025 to 6.8%. That’s roughly where the current average 30-year fixed mortgage rate stands now. Other real estate analysts, including Moody Analytics and Capital Economics, expect rates near 7% next year. This is bad news for two reasons.
November 20, 2024 | Daily JAM, Morning Briefing |
Health insurers traded higher today, November 20, after President-elect Donald Trump picked TV personality Dr. Mehmet Oz to head the U.S. Centers for Medicare and Medicaid Services, the agency responsible for overseeing healthcare coverage for millions of Americans.
November 19, 2024 | Daily JAM, GLD, GOLD, Morning Briefing, NEM, Short Term |
Gold will rally to a record next year on central-bank buying and U.S. interest rate cuts, according to Goldman Sachs. The investment bank listed the metal among top commodity trades for 2025. “Go for gold,” analysts said in a note, reiterating a target of $3,000 an ounce by December 2025.
November 18, 2024 | Daily JAM, Jubak Picks, Morning Briefing, NVDA, Top 50 Stocks |
NVIDIA (NVDA) will release its third quarter results after the market closes on Wednesday. Analysts are forecasting over 80% year over year growth in both revenue and EPS. Several Wall Street firms have raised their price targets on Nvidia ahead of its earnings report, citing strong demand for AI chips and the potential for upside surprises. Analysts from HSBC, Oppenheimer, Susquehanna, Wedbush, Raymond James, and Mizuho have increased their price targets, with HSBC setting the highest at $200. The stock closed at $140.15 on Monday, November 18. On the other hand…
November 17, 2024 | Daily JAM, Morning Briefing |
The indicator known as earnings-revision momentum— the ratio of upward versus downward revisions to analysis forecast per-share earnings over the next 12 months for the Standard & Poor’s 500 stocks—-has slumped into negative territory and is hovering near its second-worst reading in the past year, according to Bloomberg.
November 14, 2024 | Daily JAM, Morning Briefing |
I think we can expect another huge tax cut package to extend the tax cuts from 2017, and a set of tariffs on China, the European Union, and other trading partners with duties of somewhere between 20% and 200%, and an effort to deport 11 million illegal immigrants (and maybe a few legal immigrants too) And in the face of that policy mix I don’t think there’s any way for the Federal Reserve to reach its goals of getting inflation down to 2%, of lowering interest rates from levels left from the pandemic emergency, and of keeping the economy strong enough to prevent unemployment from climbing. Can’t be done. The Fed doesn’t even begin to have the tools to tackle all those challenges at once. And there’s a non-zero and statistically significant chance of a really serious mistake that would take a big bite out of the economy and the prices of financial assets. Can I tell you why I believe this?
November 13, 2024 | Daily JAM, Morning Briefing |
Inflation ticked up slightly on an annual basis in October, the latest evidence that further reductions in inflation are getting hard to achieve. The Consumer Price Index climbed 2.6% from a year earlier, up from September’s 2.4% annual rate, the Bureau of Labor Statistics reported today. Core inflation, which strips out more volatile food and energy prices, held steady at 3.3% annual rate.
